TP53 and acute myeloid leukemia: TP53MT was common in MDS and AML patients in agreement with other studies [26, 27], while our earlier analyses have shown that a second TP53 lesion was the most common hit associated with TP53MT [14] and that second TP53 hits are likely sweeping lesions [12].